The vaccine routinely used to prevent measles may hold promise for treating a common, and frequently deadly, type of blood cancer, according to new research published in Mayo Clinic Proceedings.
The vaccine routinely used to prevent measles may hold promise for treating a common, and frequently deadly, type of blood cancer, according to new research published in Mayo Clinic Proceedings.